Sinofn Health
Sinofn Health
SINOFN Health Co., Ltd. is the dedicated supplement OEM manufacturing division of SINOFN Group. Founded in 2012 and backed by the prestigious Chinese Academy of Sciences, we operate as a national high-tech enterprise. Established in 2025, our Shanghai hub serves as the gateway for global partners seeking premium, science-backed contract manufacturing.
Modern procurement is no longer just about volume; it's about transparency and bioavailability. Global brands are shifting towards R&D-integrated manufacturing where the facility provides not just assembly, but technical formulation consulting to meet specific metabolic health needs.
From FSMP (Foods for Special Medical Purposes) to daily nutraceuticals, SINOFN bridges the gap between clinical-grade requirements and mass-market consumer needs, ensuring scalability without compromising quality.
Medical Innovation Director. Ph.D Peking University Medical School. 15+ years in metabolic disorder formulations.
R&D Lead. Associate Researcher, CAS Postdoc. Specialist in bioactive compound delivery systems.
Formulation Director. Senior Scientist (Netherlands). EU regulatory specialist in nutraceutical delivery tech.
Mrs. GuoHong Liu, our founder, pioneered this path by focusing on PKU children’s health, setting a standard where "Profit with Purpose" remains our operational north star.
Our GMP production lines include 10+ dedicated lines (softgels, gummies, powders) with an annual capacity exceeding 500M+ units. We ensure ISO 22000, HACCP, and FSSC 22000 compliance.
Our testing center utilizes advanced HPLC/GC-MS technology for contaminant screening and stability validation, ensuring every batch meets international safety standards.
We hold 36 patents and 71 registered trademarks. Our team assists with global compliance, ensuring products are localized for regulatory environments including the EU, US, and SE Asia.
A: Our R&D and manufacturing centers are strategically located to integrate high-level scientific research from the Chinese Academy of Sciences with efficient industrial manufacturing hubs.
A: Yes. We offer pilot-scale prototyping for tablets, capsules, and liquids, allowing for rapid iteration and bioavailability optimization before full-scale production.
